Insider Selling: Reata Pharmaceuticals, Inc. (NASDAQ:RETA) SVP Sells $582,255.00 in Stock

Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Rating) SVP Andrea Loewen sold 6,750 shares of the business’s stock in a transaction dated Friday, May 12th. The shares were sold at an average price of $86.26, for a total transaction of $582,255.00. Following the transaction, the senior vice president now directly owns 32,007 shares in the company, […]

Related Keywords

Alger ,Algeria ,Andrea Loewen ,Robertw Baird ,Perceptive Advisors ,First Light Asset Management ,News Ratings For Reata Pharmaceuticals Daily ,Reata Pharmaceuticals ,Reata Pharmaceuticals Inc ,Deutsche Bank ,Reata Pharmaceuticals Company Profile ,Nasdaq ,Fred Alger Management ,Goldman Sachs Group ,Quarter For Reata Pharmaceuticals ,Institutional Investors Weigh In On Reata Pharmaceuticals ,Reata Pharmaceuticals Price Performance ,Cantor Fitzgerald ,Get Rating ,Light Asset Management ,Alger Management ,Reata Pharmaceuticals Daily ,Nasdaq Reta ,Greta ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,